When did VIVOS THERAPEUTICS INC (VVOS) report earnings last quarter?
VIVOS THERAPEUTICS INC (VVOS) last reported earnings on 4/2/2026.
VIVOS THERAPEUTICS INC (VVOS) Earnings History & Surprises
NASDAQ:VVOS • US92859E2072
Current stock price
1.47 USD
+0.12 (+8.89%)
At close:
1.3505 USD
-0.12 (-8.13%)
After Hours:
VVOS Earnings overview
Past quarterly earnings results for VIVOS THERAPEUTICS INC (VVOS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.49
- Revenue Estimate
- 6.576M
Last Reported
Most Recent- Release Date
- Apr 2, 2026
- Period
- Q3 / 2025
- EPS Reported
- -$0.49
- EPS Surprise
- 5.81%
- Revenue Surprise
- 38.20%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.49 | -0.52 | 5.81% | -22.50% | 6.783M | 4.908M | 38.20% | 75.73% |
| Q2 2025 | -0.55 | -0.39 | -40.06% | 8.33% | 3.82M | 3.858M | -0.98% | -5.77% |
| Q1 2025 | -0.45 | -0.41 | -10.29% | 72.39% | 3.016M | 3.74M | -19.36% | -11.79% |
| Q4 2024 | -0.28 | -0.40 | 30.50% | 90.82% | 3.698M | 3.963M | -6.69% | 13.85% |
| Q3 2024 | -0.40 | -0.62 | 35.71% | 75.31% | 3.86M | 4.142M | -6.81% | 16.93% |
| Q2 2024 | -0.60 | -1.07 | 43.98% | 86.67% | 4.054M | 3.672M | 10.40% | 19.41% |
| Q1 2024 | -1.63 | -1.20 | -36.00% | 6.86% | 3.419M | 3.479M | -1.72% | -11.36% |
| Q4 2023 | -3.05 | -1.94 | -56.97% | 39.00% | 3.248M | 3.474M | -6.51% | -17.77% |
| Q3 2023 | -1.62 | -3.19 | 49.18% | -390.91% | 3.301M | 4.223M | -21.83% | -22.33% |
| Q2 2023 | -4.50 | -3.70 | -21.70% | 45.45% | 3.395M | 4.229M | -19.72% | -18.78% |
| Q1 2023 | -1.75 | -4.59 | 61.87% | 73.08% | 3.857M | 4.086M | -5.60% | 5.96% |
| Q4 2022 | -5.00 | -5.61 | 10.87% | 41.18% | 3.95M | 4.642M | -14.91% | -10.02% |
| Q3 2022 | -0.33 | -0.27 | -22.09% | 94.92% | 4.25M | - | -6.59% | |
| Q2 2022 | -8.25 | -7.14 | -15.55% | -73.68% | 4.18M | 3.885M | 7.59% | -7.11% |
| Q1 2022 | -6.50 | -6.63 | 1.96% | -36.84% | 3.64M | 4.531M | -19.66% | 5.51% |
| Q4 2021 | -8.50 | -6.38 | -33.33% | 61.36% | 4.39M | 4.951M | -11.33% | 32.63% |
| Q3 2021 | -6.50 | -4.72 | -37.78% | - | 4.55M | 4.592M | -0.91% | 38.30% |
| Q2 2021 | -4.75 | -4.59 | -3.49% | - | 4.5M | 3.671M | 22.58% | -30.42% |
| Q1 2021 | -4.75 | -4.34 | -9.57% | - | 3.45M | 3.317M | 4.01% | - |
| Q4 2020 | -22.00 | -4.21 | -422.88% | - | 3.31M | 3.273M | 1.13% | - |
| Q3 2020 | - | - | 3.29M | - | - | |||
| Q2 2020 | - | - | 6.468M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-3.51%
Max EPS beat (4)
30.50%
Min EPS beat (4)
-40.06%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
2.79%
Max Revenue beat (4)
38.20%
Min Revenue beat (4)
-19.36%
Analysis
In the last 4 quarters, VVOS has beaten EPS estimates in 2 out of 4 releases
VVOS has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, VVOS reported -3.5% below the EPS estimates on average.
In the last 4 quarters, VVOS has beaten the revenue estimates by 2.8% on average.
Related analysis
VIVOS THERAPEUTICS INC / VVOS Earnings FAQ
Can you provide information on whether VIVOS THERAPEUTICS INC beat earnings estimates in the last quarter?
VIVOS THERAPEUTICS INC (VVOS) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does VVOS stock beat earnings estimates?
In the last 4 quarters, VIVOS THERAPEUTICS INC (VVOS) has beaten EPS estimates in 2 out of 4 releases.